2023-2028 Global and Regional Natural Killer Cell Therapies Industry Status and Prospects Professional Market Research Report Standard Version
The global Natural Killer Cell Therapies market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
By Market Verdors:
Nektar Therapeutics
Kiadis Pharma
Chipscreen Biosciences
Innate
Dragonfly Therapeutics
Affimed
Nkarta Therapeutics
Glycostem
Fate Therapeutics
NantWorks
Fortress Biotech
By Types:
NK Cell Therapies
NK Cell Directed Antibodies
By Applications:
Cancer
Gastrointestinal Diseases
Others
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2017-2028 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2017-2028. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evaluate their business approaches. Also, this report covers market segmentation by major market verdors, types, applications/end users and geography(North America, East Asia, Europe, South Asia, Southeast Asia, Middle East, Africa, Oceania, South America).
By Market Verdors:
Nektar Therapeutics
Kiadis Pharma
Chipscreen Biosciences
Innate
Dragonfly Therapeutics
Affimed
Nkarta Therapeutics
Glycostem
Fate Therapeutics
NantWorks
Fortress Biotech
By Types:
NK Cell Therapies
NK Cell Directed Antibodies
By Applications:
Cancer
Gastrointestinal Diseases
Others
Key Indicators Analysed
Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2017-2028 & Sales with a thorough analysis of the market’s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2017-2028. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
Opportunities and Drivers: Identifying the Growing Demands and New Technology
Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.
Key Reasons to Purchase
To gain insightful analyses of the market and have comprehensive understanding of the global market and its commercial landscape.
Assess the production processes, major issues, and solutions to mitigate the development risk.
To understand the most affecting driving and restraining forces in the market and its impact in the global market.
Learn about the market strategies that are being adopted by leading respective organizations.
To understand the future outlook and prospects for the market.
Besides the standard structure reports, we also provide custom research according to specific requirements.
CHAPTER 1 INDUSTRY OVERVIEW
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2023-2028)
1.4.2 East Asia Market States and Outlook (2023-2028)
1.4.3 Europe Market States and Outlook (2023-2028)
1.4.4 South Asia Market States and Outlook (2023-2028)
1.4.5 Southeast Asia Market States and Outlook (2023-2028)
1.4.6 Middle East Market States and Outlook (2023-2028)
1.4.7 Africa Market States and Outlook (2023-2028)
1.4.8 Oceania Market States and Outlook (2023-2028)
1.4.9 South America Market States and Outlook (2023-2028)
1.5 Global Natural Killer Cell Therapies Market Size Analysis from 2023 to 2028
1.5.1 Global Natural Killer Cell Therapies Market Size Analysis from 2023 to 2028 by Consumption Volume
1.5.2 Global Natural Killer Cell Therapies Market Size Analysis from 2023 to 2028 by Value
1.5.3 Global Natural Killer Cell Therapies Price Trends Analysis from 2023 to 2028
1.6 COVID-19 Outbreak: Natural Killer Cell Therapies Industry Impact
CHAPTER 2 GLOBAL NATURAL KILLER CELL THERAPIES COMPETITION BY TYPES, APPLICATIONS, AND TOP REGIONS AND COUNTRIES
2.1 Global Natural Killer Cell Therapies (Volume and Value) by Type
2.1.1 Global Natural Killer Cell Therapies Consumption and Market Share by Type (2017-2022)
2.1.2 Global Natural Killer Cell Therapies Revenue and Market Share by Type (2017-2022)
2.2 Global Natural Killer Cell Therapies (Volume and Value) by Application
2.2.1 Global Natural Killer Cell Therapies Consumption and Market Share by Application (2017-2022)
2.2.2 Global Natural Killer Cell Therapies Revenue and Market Share by Application (2017-2022)
2.3 Global Natural Killer Cell Therapies (Volume and Value) by Regions
2.3.1 Global Natural Killer Cell Therapies Consumption and Market Share by Regions (2017-2022)
2.3.2 Global Natural Killer Cell Therapies Revenue and Market Share by Regions (2017-2022)
CHAPTER 3 PRODUCTION MARKET ANALYSIS
3.1 Global Production Market Analysis
3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2017-2022 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2017-2022 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
CHAPTER 4 GLOBAL NATURAL KILLER CELL THERAPIES SALES, CONSUMPTION, EXPORT, IMPORT BY REGIONS (2017-2022)
4.1 Global Natural Killer Cell Therapies Consumption by Regions (2017-2022)
4.2 North America Natural Killer Cell Therapies Sales, Consumption, Export, Import (2017-2022)
4.3 East Asia Natural Killer Cell Therapies Sales, Consumption, Export, Import (2017-2022)
4.4 Europe Natural Killer Cell Therapies Sales, Consumption, Export, Import (2017-2022)
4.5 South Asia Natural Killer Cell Therapies Sales, Consumption, Export, Import (2017-2022)
4.6 Southeast Asia Natural Killer Cell Therapies Sales, Consumption, Export, Import (2017-2022)
4.7 Middle East Natural Killer Cell Therapies Sales, Consumption, Export, Import (2017-2022)
4.8 Africa Natural Killer Cell Therapies Sales, Consumption, Export, Import (2017-2022)
4.9 Oceania Natural Killer Cell Therapies Sales, Consumption, Export, Import (2017-2022)
4.10 South America Natural Killer Cell Therapies Sales, Consumption, Export, Import (2017-2022)
CHAPTER 5 NORTH AMERICA NATURAL KILLER CELL THERAPIES MARKET ANALYSIS
5.1 North America Natural Killer Cell Therapies Consumption and Value Analysis
5.1.1 North America Natural Killer Cell Therapies Market Under COVID-19
5.2 North America Natural Killer Cell Therapies Consumption Volume by Types
5.3 North America Natural Killer Cell Therapies Consumption Structure by Application
5.4 North America Natural Killer Cell Therapies Consumption by Top Countries
5.4.1 United States Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
5.4.2 Canada Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
5.4.3 Mexico Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
CHAPTER 6 EAST ASIA NATURAL KILLER CELL THERAPIES MARKET ANALYSIS
6.1 East Asia Natural Killer Cell Therapies Consumption and Value Analysis
6.1.1 East Asia Natural Killer Cell Therapies Market Under COVID-19
6.2 East Asia Natural Killer Cell Therapies Consumption Volume by Types
6.3 East Asia Natural Killer Cell Therapies Consumption Structure by Application
6.4 East Asia Natural Killer Cell Therapies Consumption by Top Countries
6.4.1 China Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
6.4.2 Japan Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
6.4.3 South Korea Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
CHAPTER 7 EUROPE NATURAL KILLER CELL THERAPIES MARKET ANALYSIS
7.1 Europe Natural Killer Cell Therapies Consumption and Value Analysis
7.1.1 Europe Natural Killer Cell Therapies Market Under COVID-19
7.2 Europe Natural Killer Cell Therapies Consumption Volume by Types
7.3 Europe Natural Killer Cell Therapies Consumption Structure by Application
7.4 Europe Natural Killer Cell Therapies Consumption by Top Countries
7.4.1 Germany Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
7.4.2 UK Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
7.4.3 France Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
7.4.4 Italy Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
7.4.5 Russia Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
7.4.6 Spain Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
7.4.7 Netherlands Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
7.4.8 Switzerland Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
7.4.9 Poland Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
CHAPTER 8 SOUTH ASIA NATURAL KILLER CELL THERAPIES MARKET ANALYSIS
8.1 South Asia Natural Killer Cell Therapies Consumption and Value Analysis
8.1.1 South Asia Natural Killer Cell Therapies Market Under COVID-19
8.2 South Asia Natural Killer Cell Therapies Consumption Volume by Types
8.3 South Asia Natural Killer Cell Therapies Consumption Structure by Application
8.4 South Asia Natural Killer Cell Therapies Consumption by Top Countries
8.4.1 India Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
8.4.2 Pakistan Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
8.4.3 Bangladesh Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
CHAPTER 9 SOUTHEAST ASIA NATURAL KILLER CELL THERAPIES MARKET ANALYSIS
9.1 Southeast Asia Natural Killer Cell Therapies Consumption and Value Analysis
9.1.1 Southeast Asia Natural Killer Cell Therapies Market Under COVID-19
9.2 Southeast Asia Natural Killer Cell Therapies Consumption Volume by Types
9.3 Southeast Asia Natural Killer Cell Therapies Consumption Structure by Application
9.4 Southeast Asia Natural Killer Cell Therapies Consumption by Top Countries
9.4.1 Indonesia Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
9.4.2 Thailand Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
9.4.3 Singapore Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
9.4.4 Malaysia Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
9.4.5 Philippines Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
9.4.6 Vietnam Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
9.4.7 Myanmar Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
CHAPTER 10 MIDDLE EAST NATURAL KILLER CELL THERAPIES MARKET ANALYSIS
10.1 Middle East Natural Killer Cell Therapies Consumption and Value Analysis
10.1.1 Middle East Natural Killer Cell Therapies Market Under COVID-19
10.2 Middle East Natural Killer Cell Therapies Consumption Volume by Types
10.3 Middle East Natural Killer Cell Therapies Consumption Structure by Application
10.4 Middle East Natural Killer Cell Therapies Consumption by Top Countries
10.4.1 Turkey Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
10.4.2 Saudi Arabia Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
10.4.3 Iran Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
10.4.4 United Arab Emirates Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
10.4.5 Israel Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
10.4.6 Iraq Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
10.4.7 Qatar Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
10.4.8 Kuwait Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
10.4.9 Oman Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
CHAPTER 11 AFRICA NATURAL KILLER CELL THERAPIES MARKET ANALYSIS
11.1 Africa Natural Killer Cell Therapies Consumption and Value Analysis
11.1.1 Africa Natural Killer Cell Therapies Market Under COVID-19
11.2 Africa Natural Killer Cell Therapies Consumption Volume by Types
11.3 Africa Natural Killer Cell Therapies Consumption Structure by Application
11.4 Africa Natural Killer Cell Therapies Consumption by Top Countries
11.4.1 Nigeria Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
11.4.2 South Africa Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
11.4.3 Egypt Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
11.4.4 Algeria Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
11.4.5 Morocco Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
CHAPTER 12 OCEANIA NATURAL KILLER CELL THERAPIES MARKET ANALYSIS
12.1 Oceania Natural Killer Cell Therapies Consumption and Value Analysis
12.2 Oceania Natural Killer Cell Therapies Consumption Volume by Types
12.3 Oceania Natural Killer Cell Therapies Consumption Structure by Application
12.4 Oceania Natural Killer Cell Therapies Consumption by Top Countries
12.4.1 Australia Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
12.4.2 New Zealand Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
CHAPTER 13 SOUTH AMERICA NATURAL KILLER CELL THERAPIES MARKET ANALYSIS
13.1 South America Natural Killer Cell Therapies Consumption and Value Analysis
13.1.1 South America Natural Killer Cell Therapies Market Under COVID-19
13.2 South America Natural Killer Cell Therapies Consumption Volume by Types
13.3 South America Natural Killer Cell Therapies Consumption Structure by Application
13.4 South America Natural Killer Cell Therapies Consumption Volume by Major Countries
13.4.1 Brazil Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
13.4.2 Argentina Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
13.4.3 Columbia Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
13.4.4 Chile Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
13.4.5 Venezuela Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
13.4.6 Peru Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
13.4.7 Puerto Rico Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
13.4.8 Ecuador Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
CHAPTER 14 COMPANY PROFILES AND KEY FIGURES IN NATURAL KILLER CELL THERAPIES BUSINESS
14.1 Nektar Therapeutics
14.1.1 Nektar Therapeutics Company Profile
14.1.2 Nektar Therapeutics Natural Killer Cell Therapies Product Specification
14.1.3 Nektar Therapeutics Natural Killer Cell Therapies Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.2 Kiadis Pharma
14.2.1 Kiadis Pharma Company Profile
14.2.2 Kiadis Pharma Natural Killer Cell Therapies Product Specification
14.2.3 Kiadis Pharma Natural Killer Cell Therapies Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.3 Chipscreen Biosciences
14.3.1 Chipscreen Biosciences Company Profile
14.3.2 Chipscreen Biosciences Natural Killer Cell Therapies Product Specification
14.3.3 Chipscreen Biosciences Natural Killer Cell Therapies Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.4 Innate
14.4.1 Innate Company Profile
14.4.2 Innate Natural Killer Cell Therapies Product Specification
14.4.3 Innate Natural Killer Cell Therapies Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.5 Dragonfly Therapeutics
14.5.1 Dragonfly Therapeutics Company Profile
14.5.2 Dragonfly Therapeutics Natural Killer Cell Therapies Product Specification
14.5.3 Dragonfly Therapeutics Natural Killer Cell Therapies Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.6 Affimed
14.6.1 Affimed Company Profile
14.6.2 Affimed Natural Killer Cell Therapies Product Specification
14.6.3 Affimed Natural Killer Cell Therapies Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.7 Nkarta Therapeutics
14.7.1 Nkarta Therapeutics Company Profile
14.7.2 Nkarta Therapeutics Natural Killer Cell Therapies Product Specification
14.7.3 Nkarta Therapeutics Natural Killer Cell Therapies Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.8 Glycostem
14.8.1 Glycostem Company Profile
14.8.2 Glycostem Natural Killer Cell Therapies Product Specification
14.8.3 Glycostem Natural Killer Cell Therapies Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.9 Fate Therapeutics
14.9.1 Fate Therapeutics Company Profile
14.9.2 Fate Therapeutics Natural Killer Cell Therapies Product Specification
14.9.3 Fate Therapeutics Natural Killer Cell Therapies Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.10 NantWorks
14.10.1 NantWorks Company Profile
14.10.2 NantWorks Natural Killer Cell Therapies Product Specification
14.10.3 NantWorks Natural Killer Cell Therapies Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.11 Fortress Biotech
14.11.1 Fortress Biotech Company Profile
14.11.2 Fortress Biotech Natural Killer Cell Therapies Product Specification
14.11.3 Fortress Biotech Natural Killer Cell Therapies Production Capacity, Revenue, Price and Gross Margin (2017-2022)
CHAPTER 15 GLOBAL NATURAL KILLER CELL THERAPIES MARKET FORECAST (2023-2028)
15.1 Global Natural Killer Cell Therapies Consumption Volume, Revenue and Price Forecast (2023-2028)
15.1.1 Global Natural Killer Cell Therapies Consumption Volume and Growth Rate Forecast (2023-2028)
15.1.2 Global Natural Killer Cell Therapies Value and Growth Rate Forecast (2023-2028)
15.2 Global Natural Killer Cell Therapies Consumption Volume, Value and Growth Rate Forecast by Region (2023-2028)
15.2.1 Global Natural Killer Cell Therapies Consumption Volume and Growth Rate Forecast by Regions (2023-2028)
15.2.2 Global Natural Killer Cell Therapies Value and Growth Rate Forecast by Regions (2023-2028)
15.2.3 North America Natural Killer Cell Therapies Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.4 East Asia Natural Killer Cell Therapies Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.5 Europe Natural Killer Cell Therapies Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.6 South Asia Natural Killer Cell Therapies Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.7 Southeast Asia Natural Killer Cell Therapies Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.8 Middle East Natural Killer Cell Therapies Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.9 Africa Natural Killer Cell Therapies Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.10 Oceania Natural Killer Cell Therapies Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.11 South America Natural Killer Cell Therapies Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.3 Global Natural Killer Cell Therapies Consumption Volume, Revenue and Price Forecast by Type (2023-2028)
15.3.1 Global Natural Killer Cell Therapies Consumption Forecast by Type (2023-2028)
15.3.2 Global Natural Killer Cell Therapies Revenue Forecast by Type (2023-2028)
15.3.3 Global Natural Killer Cell Therapies Price Forecast by Type (2023-2028)
15.4 Global Natural Killer Cell Therapies Consumption Volume Forecast by Application (2023-2028)
15.5 Natural Killer Cell Therapies Market Forecast Under COVID-19
CHAPTER 16 CONCLUSIONS
Research Methodology
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.4.1 North America Market States and Outlook (2023-2028)
1.4.2 East Asia Market States and Outlook (2023-2028)
1.4.3 Europe Market States and Outlook (2023-2028)
1.4.4 South Asia Market States and Outlook (2023-2028)
1.4.5 Southeast Asia Market States and Outlook (2023-2028)
1.4.6 Middle East Market States and Outlook (2023-2028)
1.4.7 Africa Market States and Outlook (2023-2028)
1.4.8 Oceania Market States and Outlook (2023-2028)
1.4.9 South America Market States and Outlook (2023-2028)
1.5 Global Natural Killer Cell Therapies Market Size Analysis from 2023 to 2028
1.5.1 Global Natural Killer Cell Therapies Market Size Analysis from 2023 to 2028 by Consumption Volume
1.5.2 Global Natural Killer Cell Therapies Market Size Analysis from 2023 to 2028 by Value
1.5.3 Global Natural Killer Cell Therapies Price Trends Analysis from 2023 to 2028
1.6 COVID-19 Outbreak: Natural Killer Cell Therapies Industry Impact
CHAPTER 2 GLOBAL NATURAL KILLER CELL THERAPIES COMPETITION BY TYPES, APPLICATIONS, AND TOP REGIONS AND COUNTRIES
2.1 Global Natural Killer Cell Therapies (Volume and Value) by Type
2.1.1 Global Natural Killer Cell Therapies Consumption and Market Share by Type (2017-2022)
2.1.2 Global Natural Killer Cell Therapies Revenue and Market Share by Type (2017-2022)
2.2 Global Natural Killer Cell Therapies (Volume and Value) by Application
2.2.1 Global Natural Killer Cell Therapies Consumption and Market Share by Application (2017-2022)
2.2.2 Global Natural Killer Cell Therapies Revenue and Market Share by Application (2017-2022)
2.3 Global Natural Killer Cell Therapies (Volume and Value) by Regions
2.3.1 Global Natural Killer Cell Therapies Consumption and Market Share by Regions (2017-2022)
2.3.2 Global Natural Killer Cell Therapies Revenue and Market Share by Regions (2017-2022)
CHAPTER 3 PRODUCTION MARKET ANALYSIS
3.1 Global Production Market Analysis
3.1.1 2017-2022 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis
3.1.2 2017-2022 Major Manufacturers Performance and Market Share
3.2 Regional Production Market Analysis
3.2.1 2017-2022 Regional Market Performance and Market Share
3.2.2 North America Market
3.2.3 East Asia Market
3.2.4 Europe Market
3.2.5 South Asia Market
3.2.6 Southeast Asia Market
3.2.7 Middle East Market
3.2.8 Africa Market
3.2.9 Oceania Market
3.2.10 South America Market
3.2.11 Rest of the World Market
CHAPTER 4 GLOBAL NATURAL KILLER CELL THERAPIES SALES, CONSUMPTION, EXPORT, IMPORT BY REGIONS (2017-2022)
4.1 Global Natural Killer Cell Therapies Consumption by Regions (2017-2022)
4.2 North America Natural Killer Cell Therapies Sales, Consumption, Export, Import (2017-2022)
4.3 East Asia Natural Killer Cell Therapies Sales, Consumption, Export, Import (2017-2022)
4.4 Europe Natural Killer Cell Therapies Sales, Consumption, Export, Import (2017-2022)
4.5 South Asia Natural Killer Cell Therapies Sales, Consumption, Export, Import (2017-2022)
4.6 Southeast Asia Natural Killer Cell Therapies Sales, Consumption, Export, Import (2017-2022)
4.7 Middle East Natural Killer Cell Therapies Sales, Consumption, Export, Import (2017-2022)
4.8 Africa Natural Killer Cell Therapies Sales, Consumption, Export, Import (2017-2022)
4.9 Oceania Natural Killer Cell Therapies Sales, Consumption, Export, Import (2017-2022)
4.10 South America Natural Killer Cell Therapies Sales, Consumption, Export, Import (2017-2022)
CHAPTER 5 NORTH AMERICA NATURAL KILLER CELL THERAPIES MARKET ANALYSIS
5.1 North America Natural Killer Cell Therapies Consumption and Value Analysis
5.1.1 North America Natural Killer Cell Therapies Market Under COVID-19
5.2 North America Natural Killer Cell Therapies Consumption Volume by Types
5.3 North America Natural Killer Cell Therapies Consumption Structure by Application
5.4 North America Natural Killer Cell Therapies Consumption by Top Countries
5.4.1 United States Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
5.4.2 Canada Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
5.4.3 Mexico Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
CHAPTER 6 EAST ASIA NATURAL KILLER CELL THERAPIES MARKET ANALYSIS
6.1 East Asia Natural Killer Cell Therapies Consumption and Value Analysis
6.1.1 East Asia Natural Killer Cell Therapies Market Under COVID-19
6.2 East Asia Natural Killer Cell Therapies Consumption Volume by Types
6.3 East Asia Natural Killer Cell Therapies Consumption Structure by Application
6.4 East Asia Natural Killer Cell Therapies Consumption by Top Countries
6.4.1 China Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
6.4.2 Japan Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
6.4.3 South Korea Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
CHAPTER 7 EUROPE NATURAL KILLER CELL THERAPIES MARKET ANALYSIS
7.1 Europe Natural Killer Cell Therapies Consumption and Value Analysis
7.1.1 Europe Natural Killer Cell Therapies Market Under COVID-19
7.2 Europe Natural Killer Cell Therapies Consumption Volume by Types
7.3 Europe Natural Killer Cell Therapies Consumption Structure by Application
7.4 Europe Natural Killer Cell Therapies Consumption by Top Countries
7.4.1 Germany Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
7.4.2 UK Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
7.4.3 France Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
7.4.4 Italy Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
7.4.5 Russia Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
7.4.6 Spain Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
7.4.7 Netherlands Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
7.4.8 Switzerland Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
7.4.9 Poland Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
CHAPTER 8 SOUTH ASIA NATURAL KILLER CELL THERAPIES MARKET ANALYSIS
8.1 South Asia Natural Killer Cell Therapies Consumption and Value Analysis
8.1.1 South Asia Natural Killer Cell Therapies Market Under COVID-19
8.2 South Asia Natural Killer Cell Therapies Consumption Volume by Types
8.3 South Asia Natural Killer Cell Therapies Consumption Structure by Application
8.4 South Asia Natural Killer Cell Therapies Consumption by Top Countries
8.4.1 India Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
8.4.2 Pakistan Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
8.4.3 Bangladesh Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
CHAPTER 9 SOUTHEAST ASIA NATURAL KILLER CELL THERAPIES MARKET ANALYSIS
9.1 Southeast Asia Natural Killer Cell Therapies Consumption and Value Analysis
9.1.1 Southeast Asia Natural Killer Cell Therapies Market Under COVID-19
9.2 Southeast Asia Natural Killer Cell Therapies Consumption Volume by Types
9.3 Southeast Asia Natural Killer Cell Therapies Consumption Structure by Application
9.4 Southeast Asia Natural Killer Cell Therapies Consumption by Top Countries
9.4.1 Indonesia Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
9.4.2 Thailand Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
9.4.3 Singapore Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
9.4.4 Malaysia Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
9.4.5 Philippines Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
9.4.6 Vietnam Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
9.4.7 Myanmar Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
CHAPTER 10 MIDDLE EAST NATURAL KILLER CELL THERAPIES MARKET ANALYSIS
10.1 Middle East Natural Killer Cell Therapies Consumption and Value Analysis
10.1.1 Middle East Natural Killer Cell Therapies Market Under COVID-19
10.2 Middle East Natural Killer Cell Therapies Consumption Volume by Types
10.3 Middle East Natural Killer Cell Therapies Consumption Structure by Application
10.4 Middle East Natural Killer Cell Therapies Consumption by Top Countries
10.4.1 Turkey Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
10.4.2 Saudi Arabia Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
10.4.3 Iran Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
10.4.4 United Arab Emirates Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
10.4.5 Israel Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
10.4.6 Iraq Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
10.4.7 Qatar Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
10.4.8 Kuwait Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
10.4.9 Oman Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
CHAPTER 11 AFRICA NATURAL KILLER CELL THERAPIES MARKET ANALYSIS
11.1 Africa Natural Killer Cell Therapies Consumption and Value Analysis
11.1.1 Africa Natural Killer Cell Therapies Market Under COVID-19
11.2 Africa Natural Killer Cell Therapies Consumption Volume by Types
11.3 Africa Natural Killer Cell Therapies Consumption Structure by Application
11.4 Africa Natural Killer Cell Therapies Consumption by Top Countries
11.4.1 Nigeria Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
11.4.2 South Africa Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
11.4.3 Egypt Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
11.4.4 Algeria Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
11.4.5 Morocco Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
CHAPTER 12 OCEANIA NATURAL KILLER CELL THERAPIES MARKET ANALYSIS
12.1 Oceania Natural Killer Cell Therapies Consumption and Value Analysis
12.2 Oceania Natural Killer Cell Therapies Consumption Volume by Types
12.3 Oceania Natural Killer Cell Therapies Consumption Structure by Application
12.4 Oceania Natural Killer Cell Therapies Consumption by Top Countries
12.4.1 Australia Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
12.4.2 New Zealand Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
CHAPTER 13 SOUTH AMERICA NATURAL KILLER CELL THERAPIES MARKET ANALYSIS
13.1 South America Natural Killer Cell Therapies Consumption and Value Analysis
13.1.1 South America Natural Killer Cell Therapies Market Under COVID-19
13.2 South America Natural Killer Cell Therapies Consumption Volume by Types
13.3 South America Natural Killer Cell Therapies Consumption Structure by Application
13.4 South America Natural Killer Cell Therapies Consumption Volume by Major Countries
13.4.1 Brazil Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
13.4.2 Argentina Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
13.4.3 Columbia Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
13.4.4 Chile Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
13.4.5 Venezuela Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
13.4.6 Peru Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
13.4.7 Puerto Rico Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
13.4.8 Ecuador Natural Killer Cell Therapies Consumption Volume from 2017 to 2022
CHAPTER 14 COMPANY PROFILES AND KEY FIGURES IN NATURAL KILLER CELL THERAPIES BUSINESS
14.1 Nektar Therapeutics
14.1.1 Nektar Therapeutics Company Profile
14.1.2 Nektar Therapeutics Natural Killer Cell Therapies Product Specification
14.1.3 Nektar Therapeutics Natural Killer Cell Therapies Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.2 Kiadis Pharma
14.2.1 Kiadis Pharma Company Profile
14.2.2 Kiadis Pharma Natural Killer Cell Therapies Product Specification
14.2.3 Kiadis Pharma Natural Killer Cell Therapies Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.3 Chipscreen Biosciences
14.3.1 Chipscreen Biosciences Company Profile
14.3.2 Chipscreen Biosciences Natural Killer Cell Therapies Product Specification
14.3.3 Chipscreen Biosciences Natural Killer Cell Therapies Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.4 Innate
14.4.1 Innate Company Profile
14.4.2 Innate Natural Killer Cell Therapies Product Specification
14.4.3 Innate Natural Killer Cell Therapies Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.5 Dragonfly Therapeutics
14.5.1 Dragonfly Therapeutics Company Profile
14.5.2 Dragonfly Therapeutics Natural Killer Cell Therapies Product Specification
14.5.3 Dragonfly Therapeutics Natural Killer Cell Therapies Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.6 Affimed
14.6.1 Affimed Company Profile
14.6.2 Affimed Natural Killer Cell Therapies Product Specification
14.6.3 Affimed Natural Killer Cell Therapies Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.7 Nkarta Therapeutics
14.7.1 Nkarta Therapeutics Company Profile
14.7.2 Nkarta Therapeutics Natural Killer Cell Therapies Product Specification
14.7.3 Nkarta Therapeutics Natural Killer Cell Therapies Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.8 Glycostem
14.8.1 Glycostem Company Profile
14.8.2 Glycostem Natural Killer Cell Therapies Product Specification
14.8.3 Glycostem Natural Killer Cell Therapies Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.9 Fate Therapeutics
14.9.1 Fate Therapeutics Company Profile
14.9.2 Fate Therapeutics Natural Killer Cell Therapies Product Specification
14.9.3 Fate Therapeutics Natural Killer Cell Therapies Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.10 NantWorks
14.10.1 NantWorks Company Profile
14.10.2 NantWorks Natural Killer Cell Therapies Product Specification
14.10.3 NantWorks Natural Killer Cell Therapies Production Capacity, Revenue, Price and Gross Margin (2017-2022)
14.11 Fortress Biotech
14.11.1 Fortress Biotech Company Profile
14.11.2 Fortress Biotech Natural Killer Cell Therapies Product Specification
14.11.3 Fortress Biotech Natural Killer Cell Therapies Production Capacity, Revenue, Price and Gross Margin (2017-2022)
CHAPTER 15 GLOBAL NATURAL KILLER CELL THERAPIES MARKET FORECAST (2023-2028)
15.1 Global Natural Killer Cell Therapies Consumption Volume, Revenue and Price Forecast (2023-2028)
15.1.1 Global Natural Killer Cell Therapies Consumption Volume and Growth Rate Forecast (2023-2028)
15.1.2 Global Natural Killer Cell Therapies Value and Growth Rate Forecast (2023-2028)
15.2 Global Natural Killer Cell Therapies Consumption Volume, Value and Growth Rate Forecast by Region (2023-2028)
15.2.1 Global Natural Killer Cell Therapies Consumption Volume and Growth Rate Forecast by Regions (2023-2028)
15.2.2 Global Natural Killer Cell Therapies Value and Growth Rate Forecast by Regions (2023-2028)
15.2.3 North America Natural Killer Cell Therapies Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.4 East Asia Natural Killer Cell Therapies Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.5 Europe Natural Killer Cell Therapies Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.6 South Asia Natural Killer Cell Therapies Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.7 Southeast Asia Natural Killer Cell Therapies Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.8 Middle East Natural Killer Cell Therapies Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.9 Africa Natural Killer Cell Therapies Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.10 Oceania Natural Killer Cell Therapies Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.2.11 South America Natural Killer Cell Therapies Consumption Volume, Revenue and Growth Rate Forecast (2023-2028)
15.3 Global Natural Killer Cell Therapies Consumption Volume, Revenue and Price Forecast by Type (2023-2028)
15.3.1 Global Natural Killer Cell Therapies Consumption Forecast by Type (2023-2028)
15.3.2 Global Natural Killer Cell Therapies Revenue Forecast by Type (2023-2028)
15.3.3 Global Natural Killer Cell Therapies Price Forecast by Type (2023-2028)
15.4 Global Natural Killer Cell Therapies Consumption Volume Forecast by Application (2023-2028)
15.5 Natural Killer Cell Therapies Market Forecast Under COVID-19
CHAPTER 16 CONCLUSIONS
Research Methodology
